A Culture of Pragmatism

Lori A. Ball is the Chief Executive Officer of Astoriom, where she leads the company’s profitable growth and global expansion in the pharmaceutical, biologics, and medical device industries. With a focus on high-quality biospecimen storage and sample stability, Ms. Ball leverages her extensive experience to drive strategic initiatives and operational excellence at Astoriom.

An accomplished executive, Lori has held several C-level positions in the CRO, sample storage, and laboratory research industries. Ms. Ball’s career includes leadership roles at StageBio, BioIVT, LAB Strategies, and BioStorage Technologies, Inc. (now Azenta Life Sciences), as well as Covance, Inc. (now Labcorp). Lori has a proven track record of successful geographic expansions, profitable growth, and mergers and acquisitions, particularly in the life science R&D industry. Lori is recognized as a keynote speaker, published author, and Six Sigma business process methodology expert.

Philip Bradley is the General Manager at Astoriom, bringing nearly a decade of experience within the life sciences industry. Specializing in stability storage services, Philip oversees operations across Astoriom’s multiple locations, ensuring the delivery of high-quality, temperature-controlled solutions that meet stringent compliance standards.

Philip’s customer-centric approach and deep understanding of the industry have been instrumental in enhancing operational efficiency and service delivery at Astoriom. His role is crucial in maintaining the company’s commitment to quality and customer satisfaction, positioning Astoriom as a leader in the stability storage sector.

Jack Grimshaw is the Chief Financial Officer at Astoriom, where he’s driving the company’s growth in biorepository services and expanding its market presence in the US and Europe. With a robust background in high-growth financial management, Jack plays a pivotal role in scaling businesses and driving profitability.

Before joining Astoriom, Jack served as CFO at Maxwellia, where he led finance and supply chain teams, secured funding from investors, and facilitated significant product launches, including transitioning prescription products to over-the-counter availability. His early career at Sainsbury’s saw him manage the pharmacy and healthcare finance team, contributing to the business’s growth. Jack’s leadership style, characterized by openness and collaboration, is complemented by his personal commitment to a balanced and active lifestyle.

Mark Hammond serves as the Executive Chairman at Astoriom, bringing over 30 years of experience in contract laboratory and outsourced storage services for the Medical Device and Pharmaceutical industries. In his role, Mark applies his extensive leadership, commercial insight, and technical expertise to drive Astoriom’s strategic growth and operations.

Trained as an analytical chemist, Mark has a deep understanding of the life sciences sector, which he has leveraged throughout his diverse roles to foster innovation and growth. Mark is also the CEO of Cormica, where he has led significant mergers and acquisitions, including the integration of four businesses. His career includes notable positions such as CEO of Melbourn Scientific, Head of the UK Chemical & Pharmaceutical division at Intertek, and Commercial Director at Aesica Pharmaceuticals.